|
ctDNA Detection in Patients with Solid Tumors and Known Brain Metastases: A Duke Experience/Activity of the Tumor-intrinsic NLRP3 Inflammasome Pathway Predicts for Response to Checkpoint Inhibitor Immunotherapy in Melanoma Patients” |
07/27/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
08/24/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
09/14/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
08/10/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
02/23/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
02/02/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
09/21/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
01/26/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
10/19/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
10/05/2022 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward